Qiagen N.V. (QGEN) Financials

QGEN Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 5.9 billion 2.5 billion
March 31, 2026 5.8 billion 2.5 billion
Dec. 31, 2025 6.3 billion 2.5 billion
Sept. 30, 2025 6.6 billion 2.9 billion

QGEN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 157.8 million 7.0 million
March 31, 2026 53.7 million 9.7 million
Dec. 31, 2025 117.2 million 16.6 million
Sept. 30, 2025 119.0 million 10.7 million

QGEN Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 103.4 million
March 31, 2026 68.0 million
Dec. 31, 2025 107.8 million
Sept. 30, 2025 130.0 million

QGEN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 793.5 million 1.6 billion -
March 31, 2026 646.3 million 1.6 billion -
Dec. 31, 2025 1.1 billion 1.7 billion 157.9 million
Sept. 30, 2025 1.7 billion 1.6 billion -

QGEN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 207.8 million
March 31, 2026 208.9 million
Dec. 31, 2025 207.8 million
Sept. 30, 2025 218.5 million

QGEN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 42.9 million 50.4 million 146.8 million -
March 31, 2026 46.9 million 48.3 million 142.4 million 114.6 million
Dec. 31, 2025 70.9 million 47.2 million 153.9 million 120.7 million
Sept. 30, 2025 46.0 million 48.7 million 143.1 million 112.8 million

QGEN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 535.0 million 197.0 million
March 31, 2026 492.3 million 182.7 million
Dec. 31, 2025 540.4 million 223.2 million
Sept. 30, 2025 532.6 million 201.3 million

QGEN

Price: $43.47

52 week price:
30.63
57.82

Dividend Yield: 0.83%

5-year range yield:
0.53%
4.49%

Forward Dividend Yield: 0.81%

Payout Ratio: 377.03%

Payout Ratio Range:
41.71%
1488.21%

Dividend Per Share: 0.35 USD

Earnings Per Share: 1.91 USD

P/E Ratio: 22.33

Exchange: NYQ

Sector: Healthcare

Industry: Diagnostics & Research

Country: Netherlands

Volume: 670300

Ebitda: 103.6 million

Market Capitalization: 8.8 billion

Average Dividend Frequency: 1

Years Paying Dividends: 3

Links: